Highly Uncontrolled Cardiovascular Risk in Emerging Adults With Paediatric-Onset Type 1 Diabetes-A Cross-Sectional Analysis From the Diabetes Prospective Follow-Up Registry DPV. [PDF]
ABSTRACT Aims Cardiovascular disease (CVD) is a major contributor to premature morbidity and mortality in individuals with type 1 diabetes (T1DM). Glycaemic control often deteriorates during the transition from paediatric to adult care, and thus we assessed the prevalence and pharmacological management of overt and actionable modifiable cardiovascular ...
Welters A +9 more
europepmc +2 more sources
Screening for microalbuminuria [PDF]
Contains fulltext : 48389.pdf (Publisher’s version ) (Open Access)
Hilbrands, L.B. +2 more
openaire +3 more sources
The capacity of microalbuminuria to predict an increased cardiovascular and renal risk is well established in diabetic patients, as well as in essential hypertensive patients and in general population. Detection of microalbuminuria could then be relevant to select specific therapeutic strategies for reducing or preventing cardiovascular events in ...
J, Segura, L M, Ruilope, J L, Rodicio
openaire +2 more sources
Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis [PDF]
OBJECTIVE: Glycemic variability is emerging as a measure of glycemic control, which may be a reliable predictor of complications. This systematic review and meta-analysis evaluates the association between HbA1c variability and micro- and macrovascular ...
Catherine Gorst +18 more
core +1 more source
Elevated cystatin-C concentration is associated with progression to prediabetes: the Western New York Study [PDF]
OBJECTIVE – We conducted a nested case-control investigation to examine if elevated baseline concentrations of cystatin-C predicted progression from normoglycaemia to prediabetes over 6 years of follow-up from the Western New York Health Study. RESEARCH
Dmochowski, Jacek +5 more
core +1 more source
Introduction: Diabetic nephropathy is leading cause of morbidity and mortality of type 1 diabetes mellitus (DM). Microalbuminuria is the first clinical sign of nephropathy.
Bedowra Zabeen +4 more
doaj +1 more source
Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial [PDF]
Introduction: Diabetes mellitus affects 9% of the European population and accounts for 15% of healthcare expenditure, in particular, due to excess costs related to complications.
Beige, Joachim +14 more
core +4 more sources
Microalbuminuria - A better marker in hypertensive disorders of pregnancy
To assess the role of microalbuminuria in pre-eclampsia (PE) as a diagnostic marker, we studied 40 PE cases and 40 normotensive controls at 24 ± 4 weeks of gestation in women 20-35 years of age.
Ruby P Babu +4 more
doaj +1 more source
Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria [PDF]
Background: The urinary proteomic classifier CKD273 has shown promise for prediction of progressive diabetic nephropathy (DN). Whether it is also a determinant of mortality and cardiovascular disease in patients with microalbuminuria (MA) is unknown.
Currie, Gemma E. +11 more
core +2 more sources
The impact of nonalcoholic fatty liver disease on renal function in children with overweight/obesity [PDF]
The association between nonalcoholic fatty liver disease (NAFLD) and chronic kidney disease has attracted interest and attention over recent years. However, no data are available in children.
Andreoli, Gian Marco +6 more
core +2 more sources

